The "doses" of initial, untreated hallucinations and delusions: A proof-of-concept study of enhanced predictors of first-episode symptomatology and functioning relative to duration of untreated psychosis

Journal of Clinical Psychiatry

Volumn 72, Issue 11, 2011, Pages 1487-1493

  Compton, Michael T ^a,d   Gordon, Tynessa L ^a   Weiss, Paul S ^b   Walker, Elaine F ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BRIEF PSYCHOTIC DISORDER; DELUSION; DELUSIONAL DISORDER; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; GENDER; HALLUCINATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOPATHY; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SOCIAL PSYCHOLOGY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

EID: 81755173966     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05841yel     Document Type: Article

References (51)

1. McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry. 1999;46(7):899-907. doi:10.1016/S06-323(9)084-0 PubMed (Pubitemid 29452981)
2. Norman RMG, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med. 2001;31(3):381-400. doi:10.1017/S032917010348 PubMed (Pubitemid 32294037)
3. Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62(9):975-983. doi:10.101/archpsyc. 62.9.975 PubMed (Pubitemid 41248376)
4. Perkins DO, Gu H, Boteva K, et al. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005;162(10):1785-1804. doi:10.176/api.ajp.162.10.1785 PubMed (Pubitemid 41428609)
5. Emsley R, Rabinowitz J, Medori R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatry. 2006;163(4):743-745. doi:10.176/api.ajp.163.4.743 PubMed (Pubitemid 44464590)
6. Clarke M, Whitty P, Browne S, et al. Untreated illness and outcome of psychosis. Br J Psychiatry. 2006;189(3):235-240. doi:10.192/bjp.bp.105.014068 PubMed (Pubitemid 44343468)
7. Robinson DG, Woerner MG, McMeniman M, et al. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2004;161(3):473-479. doi:10.176/api.ajp.161.3.473 PubMed (Pubitemid 38326102)
8. Norman RMG, Malla AK, Manchanda R, et al. Does treatment delay predict occupational functioning in first-episode psychosis? Schizophr Res. 2007;91(1-3):259-262. doi:10.1016/j.schres.206.12.024 PubMed
9. Singh SP, Burns T, Amin S, et al. Acute and transient psychotic disorders: precursors, epidemiology, course and outcome. Br J Psychiatry. 2004;185(6):452-459. doi:10.192/bjp.185.6.452 PubMed (Pubitemid 39643279)
10. Verdoux H, Liraud F, Bergey C, et al. Is the association between duration of untreated psychosis and outcome confounded? a two year follow-up study of first-admitted patients. Schizophr Res. 2001;49(3):231-241. doi:10.1016/S0920- 964(0)072-4 PubMed (Pubitemid 32453224)
11. Perkins DO, Lieberman JA, Gu H, et al. HGDH Research Group. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry. 2004;185(1):18-24. doi:10.192/bjp.185.1.18 PubMed (Pubitemid 38951625)
12. Uçok A, Polat A, Genç A, et al. Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J Psychiatr Res. 2004;38(2):163-168. doi:10.1016/S02-3956(03)0104-3 PubMed
13. Larsen TK, Moe LC, Vibe-Hansen L, et al. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res. 2000;45(1-2):1-9. doi:10.1016/S0920-964(9)0169-3 PubMed
14. Harrigan SM, McGorry PD, Krstev H. Does treatment delay in firstepisode psychosis really matter? Psychol Med. 2003;33(1):97-110. doi:10.1017/ S032917020675X PubMed (Pubitemid 36113405)
15. Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychol Med. 2004;34(2):277-284. doi:10.1017/S032917030156 PubMed (Pubitemid 38239635)
16. Norman RMG, Malla AK, Manchanda R. Early premorbid adjustment as a moderator of the impact of duration of untreated psychosis. Schizophr Res. 2007;95(1-3):111-114. doi:10.1016/j.schres.207.06.07 PubMed (Pubitemid 47313646)
17. McGlashan TH. Premorbid adjustment, onset types, and prognostic scaling: still informative? Schizophr Bull. 2008;34(5):801-805. doi:10.1093/schbul/sbn073 PubMed
18. Melle I, Larsen TK, Haahr U, et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry. 2004;61(2):143-150. doi:10.101/archpsyc.61.2.143 PubMed (Pubitemid 38146548)
19. Joa I, Johannessen JO, Auestad B, et al. The key to reducing duration of untreated first psychosis: information campaigns. Schizophr Bull. 2008;34(3):466-472. doi:10.1093/schbul/sbm095 PubMed
20. Compton MT, Carter T, Bergner E, et al. Defining, operationalizing, and measuring the duration of untreated psychosis: advances, limitations and future directions. Early Interv Psychiatry. 2007;1(3):236-250. doi:10.1/j.1751-7893. 207.036.x
21. Waddington JL, Youssef HA, Kinsella A. Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychol Med. 1995;25(4):849-857. doi:10.1017/S032917035108 PubMed
22. Sheitman BB, Lieberman JA. The natural history and pathophysiology of treatment resistant schizophrenia. J Psychiatr Res. 1998;32(3-4):143-150. doi:10.1016/S02-3956(97)052-6 PubMed (Pubitemid 28408278)
23. Norman RMG, Townsend L, Malla AK. Duration of untreated psychosis and cognitive functioning in first-episode patients. Br J Psychiatry. 2001;179(4):340-345. doi:10.192/bjp.179.4.340 PubMed (Pubitemid 32996044)
24. Norman RMG, Malla AK, Manchanda R. Is untreated psychosis socially toxic? Early Interv Psychiatry. 2007;1(3):267-270. doi:10.1/j.1751-7893.207.038.x
25. Ho BC, Alicata D, Ward J, et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry. 2003;160(1):142-148. doi:10.176/api.ajp.160.1.142 PubMed (Pubitemid 36042438)
26. Gunduz-Bruce H, McMeniman M, Robinson DG, et al. Duration of untreated psychosis and time to treatment response for delusions and hallucinations. Am J Psychiatry. 2005;162(10):1966-1969. doi:10.176/api.ajp.162.10.196 PubMed (Pubitemid 41428630)
27. Compton MT, Chien VH, Leiner AS, et al. Mode of onset of psychosis and family involvement in help-seeking as determinants of duration of untreated psychosis. Soc Psychiatry Psychiatr Epidemiol. 2008;43(12):975-982. doi:10.107/s0127-08-0397-y PubMed
28. Compton MT, Gordon TL, Goulding SM, et al. Patient-level predictors and clinical correlates of duration of untreated psychosis among hospitalized first-episode patients. J Clin Psychiatry. 2011;72(2):225-232. doi:10.408/JCP.09m05704yel PubMed
29. Compton MT, Goulding SM, Gordon TL, et al. Family-level predictors and correlates of the duration of untreated psychosis in African American first-episode patients. Schizophr Res. 2009;115(2-3):338-345. doi:10.1016/j.schres.209.09.029 PubMed
30. Compton MT, Ramsay CE, Shim RS, et al. Health services determinants of the duration of untreated psychosis among African-American first-episode patients. Psychiatr Serv. 2009;60(11):1489-1494. doi:10.176/api.ps.60.1.1489 PubMed
31. Goulding SM, Chien VH, Compton MT. Prevalence and correlates of school drop-out prior to initial treatment of nonaffective psychosis: further evidence suggesting a need for supported education. Schizophr Res. 2010;116(2-3):228-233. doi:10.1016/j.schres.209.09.06 PubMed
32. Ramsay CE, Goulding SM, Broussard B, et al. From handcuffs to hallucinations: prevalence and psychosocial correlates of prior incarceration in an urban, predominantly African American sample of hospitalized patients with first-episode psychosis. J Am Acad Psychiatry Law. In press.
33. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders. New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1998.
34. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8(3):470-484. PubMed
35. Alvarez E, Garcia-Ribera C, Torrens M, et al. Premorbid Adjustment Scale as a prognostic predictor for schizophrenia. Br J Psychiatry. 1987;150(3):411. doi:10.192/bjp.150.3.41 PubMed
36. Krauss H, Marwinski K, Held T, et al. Reliability and validity of the Premorbid Adjustment Scale (PAS) in a German sample of schizophrenic and schizoaffective patients. Eur Arch Psychiatry Clin Neurosci. 1998;248(6):277-281. doi:10.107/s040605050 PubMed (Pubitemid 29026982)
37. Monte RC, Goulding SM, Compton MT. Premorbid functioning of patients with first-episode nonaffective psychosis: a comparison of deterioration in academic and social performance, and clinical correlates of Premorbid Adjustment Scale scores. Schizophr Res. 2008;104(1-3):206-213. doi:10.1016/j.schres.208.06.09 PubMed
38. Perkins DO, Leserman J, Jarskog LF, et al. Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophr Res. 2000;44(1):1-10. doi:10.1016/S0920-964(9)0161-9 PubMed (Pubitemid 30365202)
39. Norman RMG, Malla AK. Course of Onset and Relapse Schedule: Interview and Coding Instruction Guide. London, Ontario: Prevention and Early Intervention for Psychosis Program; 2002.
40. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276. PubMed (Pubitemid 18039085)
41. Haddock G, McCarron J, Tarrier N, et al. Scales to measure dimensions of hallucinations and delusions: the Psychotic Symptom Rating Scales (PSYRATS). Psychol Med. 1999;29(4):879-889. doi:10.1017/S03291790861 PubMed (Pubitemid 29381048)
42. Drake R, Haddock G, Tarrier N, et al. The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis. Schizophr Res. 2007;89(1-3):119-122. doi:10.1016/j.schres.206.04.024 PubMed (Pubitemid 44911085)
43. Birchwood M, Smith J, Drury V, et al. A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand. 1994;89(1):62-67. doi:10.1/j.160-047.194.tb01487.x PubMed (Pubitemid 24028268)
44. Karow A, Pajonk FG, Reimer J, et al. The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life. Eur Arch Psychiatry Clin Neurosci. 2008;258(3):152-159. doi:10.107/s0406-07-0768-5 PubMed (Pubitemid 351642152)
45. American Psychiatric Association. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000.
46. Goldman HH, Skodol AE, Lave TR. Revising Axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry. 1992;149(9):1148-1156. PubMed
47. Dickerson FB, Boronow JJ, Ringel N, et al. Lack of insight among outpatients with schizophrenia. Psychiatr Serv. 1997;48(2):195-199. PubMed (Pubitemid 27057401)
48. Kim Y, Sakamoto K, Kamo T, et al. Insight and clinical correlates in schizophrenia. Compr Psychiatry. 1997;38(2):117-123. doi:10.1016/S010-40X(97) 9091-2 PubMed
49. Sanz M, Constable G, Lopez-Ibor I, et al. A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychol Med. 1998;28(2):437-446. doi:10.1017/S0329179706296 PubMed (Pubitemid 28197558)
50. Bechard-Evans L, Schmitz N, Abadi S, et al. Determinants of help-seeking and system related components of delay in the treatment of first-episode psychosis. Schizophr Res. 2007;96(1-3):206-214. doi:10.1016/j.schres.207.07.017 PubMed (Pubitemid 47494636)
51. Murphy BP, Stuart AH, McGorry PD. Duration of untreated negative symptoms and duration of active negative symptoms: proof of concepts. Early Interv Psychiatry. 2008;2(1):27-33. doi:10.1/j.1751-7893.207.053.x